{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:54:58Z","timestamp":1790776498184,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ctim.2018.07.016","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T12:38:03Z","timestamp":1533127083000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile"],"prefix":"10.1016","volume":"40","author":[{"given":"Antonia","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Simian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Quera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Lubascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Kronberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Flux\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (12)","key":"10.1016\/j.ctim.2018.07.016_bib0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrgastro.2017.110","article-title":"The IBD interactome: an integrated view of etiology, pathogenesis and therapy","volume":"14","author":"de Souza","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ctim.2018.07.016_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ctim.2018.07.016_bib0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5217\/ir.2017.15.3.338","article-title":"Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases","volume":"15","author":"Kim","year":"2017","journal-title":"Intest Res"},{"issue":"21","key":"10.1016\/j.ctim.2018.07.016_bib0020","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.ctim.2018.07.016_bib0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"issue":"May (6)","key":"10.1016\/j.ctim.2018.07.016_bib0030","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"issue":"June (22)","key":"10.1016\/j.ctim.2018.07.016_bib0035","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.3748\/wjg.v22.i22.5267","article-title":"Inflammatory bowel disease: a descriptive study of 716 local Chilean patients","volume":"22","author":"Simian","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"March (3)","key":"10.1016\/j.ctim.2018.07.016_bib0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/17474124.2014.881715","article-title":"Adverse events in IBD: to stop or continue immune suppressant and biologic treatment","volume":"8","author":"McLean","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"December (4)","key":"10.1016\/j.ctim.2018.07.016_bib0045","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.gtc.2017.08.001","article-title":"Use of complementary and alternative medicine in inflammatory bowel disease around the world","volume":"46","author":"Zezos","year":"2017","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.ctim.2018.07.016_bib0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/MIB.0b013e31827f27c8","article-title":"Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study","volume":"19","author":"Koning","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ctim.2018.07.016_bib0055","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.crohns.2014.08.013","article-title":"Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease","volume":"8","author":"Mountifield","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"February (1)","key":"10.1016\/j.ctim.2018.07.016_bib0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ctim.2013.12.001","article-title":"Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea","volume":"22","author":"Park","year":"2014","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.ctim.2018.07.016_bib0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MEG.0000000000000040","article-title":"Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey","volume":"26","author":"Abitbol","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"January (1)","key":"10.1016\/j.ctim.2018.07.016_bib0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0399-8320(06)73072-X","article-title":"Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey","volume":"30","author":"Bensoussan","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"issue":"June (6)","key":"10.1016\/j.ctim.2018.07.016_bib0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.dld.2007.03.001","article-title":"Use of alternative and complementary therapies by inflammatory bowel disease patients in an Italian tertiary referral center","volume":"39","author":"D\u2019Inca","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"June (6)","key":"10.1016\/j.ctim.2018.07.016_bib0080","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/MIB.0000000000000773","article-title":"Use of complementary and alternative medicine for inflammatory bowel disease is associated with worse adherence to conventional therapy: the COMPLIANT study","volume":"22","author":"Nguyen","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"April (4)","key":"10.1016\/j.ctim.2018.07.016_bib0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.dld.2016.12.031","article-title":"The who-when-why triangle of CAM use among Portuguese IBD patients","volume":"49","author":"Portela","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"November (11)","key":"10.1016\/j.ctim.2018.07.016_bib0090","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/MEG.0000000000000710","article-title":"Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study","volume":"28","author":"Oxelmark","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"September (3)","key":"10.1016\/j.ctim.2018.07.016_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.crohns.2009.11.011","article-title":"Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease","volume":"4","author":"Lakatos","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"March (1)","key":"10.1016\/j.ctim.2018.07.016_bib0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ctim.2006.03.008","article-title":"Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use","volume":"15","author":"Langhorst","year":"2007","journal-title":"Complement Ther Med"},{"issue":"January (1)","key":"10.1016\/j.ctim.2018.07.016_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9343(02)01383-9","article-title":"Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis","volume":"114","author":"Kane","year":"2003","journal-title":"Am J Med"},{"issue":"March (3)","key":"10.1016\/j.ctim.2018.07.016_bib0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ajg.2009.685","article-title":"Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review","volume":"105","author":"Jackson","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"March (Suppl. 1)","key":"10.1016\/j.ctim.2018.07.016_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2036.2008.03604.x","article-title":"Review article: improving adherence to medication in patients with inflammatory bowel disease","volume":"27","author":"Robinson","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"March (12)","key":"10.1016\/j.ctim.2018.07.016_bib0120","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3748\/wjg.v21.i12.3663","article-title":"Doctor communication quality and friends\u2019 attitudes influence complementary medicine use in inflammatory bowel disease","volume":"21","author":"Mountifield","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"March (1)","key":"10.1016\/j.ctim.2018.07.016_bib0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0965-2299(02)00107-3","article-title":"Inflammatory bowel disease patients\u2019 decisions to use complementary therapies: links to existing models of care","volume":"11","author":"Scott","year":"2003","journal-title":"Complement Ther Med"},{"issue":"October","key":"10.1016\/j.ctim.2018.07.016_bib0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1472-6882-14-407","article-title":"Experiences of complementary and alternative medicine in patients with inflammatory bowel disease\u2014a qualitative study","volume":"14","author":"Lindberg","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.ctim.2018.07.016_bib0135","series-title":"Final report: \u201cStudy about knowledge, utilization and degree of satisfaction in the Chilean population with regards to complementary and alternative medicine\u201d","year":"2012"},{"key":"10.1016\/j.ctim.2018.07.016_bib0140","first-page":"S6","article-title":"Complementary and alternative medicine in brazilian patients with inflammatory bowel diseases","volume":"113","author":"Henriques","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"February (2)","key":"10.1016\/j.ctim.2018.07.016_bib0145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ibd.21360","article-title":"Use of complementary and alternative medicine by patients with inflammatory bowel disease","volume":"17","author":"Hilsden","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"March (3)","key":"10.1016\/j.ctim.2018.07.016_bib0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.MIB.0000160771.71328.6c","article-title":"Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey","volume":"11","author":"Langhorst","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ctim.2018.07.016_bib0155","first-page":"106","article-title":"Prevalence and demographic characteristics of inflammatory bowel disease in Cartagena, Colombia","volume":"25","author":"Yepes","year":"2010","journal-title":"Rev Colomb Gastroenterol"},{"issue":"September (3)","key":"10.1016\/j.ctim.2018.07.016_bib0160","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.crohns.2009.12.009","article-title":"Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study","volume":"4","author":"Bertomoro","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"November (11)","key":"10.1016\/j.ctim.2018.07.016_bib0165","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.dld.2012.06.008","article-title":"Complementary and alternative medicine in inflammatory bowel disease patients: frequency and risk factors","volume":"44","author":"Fern\u00e1ndez","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"July (7)","key":"10.1016\/j.ctim.2018.07.016_bib0170","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1572-0241.2003.07519.x","article-title":"Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey","volume":"98","author":"Hilsden","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"October (6)","key":"10.1016\/j.ctim.2018.07.016_bib0175","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ejim.2009.04.006","article-title":"Placebo therapy in Crohn\u2019s disease","volume":"20","author":"Renna","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"March\u2013April (4)","key":"10.1016\/j.ctim.2018.07.016_bib0180","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/MIB.0b013e31827f27c8","article-title":"Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study","volume":"19","author":"Koning","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"February (3)","key":"10.1016\/j.ctim.2018.07.016_bib0185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2036.2011.04956.x","article-title":"Characterization of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease","volume":"35","author":"Weizman","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.ctim.2018.07.016_bib0190","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3109\/00365521.2012.725092","article-title":"Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway","volume":"47","author":"Opheim","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"April (4)","key":"10.1016\/j.ctim.2018.07.016_bib0195","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4067\/S0034-98872016000400010","article-title":"Towards an integral management of inflammatory bowel disease","volume":"144","author":"Simian","year":"2016","journal-title":"Rev Med Chil"},{"issue":"February (2)","key":"10.1016\/j.ctim.2018.07.016_bib0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1572-0241.2004.04046.x","article-title":"Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic?","volume":"99","author":"Ganguli","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"June (23)","key":"10.1016\/j.ctim.2018.07.016_bib0205","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"issue":"September (1)","key":"10.1016\/j.ctim.2018.07.016_bib0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jep.2008.06.022","article-title":"Antinociceptive activity of Buddleja globosa (matico) in several models of pain","volume":"119","author":"Backhouse","year":"2008","journal-title":"J Ethnopharmacol"},{"issue":"March (2)","key":"10.1016\/j.ctim.2018.07.016_bib0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jep.2007.11.025","article-title":"Analgesic, anti-inflammatory and antioxidant properties of Buddleja globosa, Buddlejaceae","volume":"116","author":"Backhouse","year":"2008","journal-title":"J Ethnopharmacol"},{"issue":"June (3)","key":"10.1016\/j.ctim.2018.07.016_bib0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00232-017-9955-0","article-title":"An in vitro study of the antioxidant and antihemolytic properties of Buddleja globosa (Matico)","volume":"250","author":"Suwalsky","year":"2017","journal-title":"J Membr Biol"},{"issue":"November (6)","key":"10.1016\/j.ctim.2018.07.016_bib0225","first-page":"895","article-title":"Chamomile: a herbal medicine of the past with bright future","volume":"3","author":"Srivastava","year":"2010","journal-title":"Mol Med Rep"},{"issue":"December (13)","key":"10.1016\/j.ctim.2018.07.016_bib0230","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1097\/01.MIB.0000435851.94391.37","article-title":"Marijuana use patterns among patients with inflammatory bowel disease","volume":"19","author":"Ravikoff Allegretti","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"March (3)","key":"10.1016\/j.ctim.2018.07.016_bib0235","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/MIB.0000000000000629","article-title":"A controlled study of a group mindfulness intervention for individuals living with inflammatory bowel disease","volume":"22","author":"Neilson","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"December (4)","key":"10.1016\/j.ctim.2018.07.016_bib0240","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.gtc.2017.08.008","article-title":"Mindfulness-based interventions in inflammatory bowel disease","volume":"46","author":"Hood","year":"2017","journal-title":"Gastroenterol Clin N Am"},{"issue":"April (4)","key":"10.1016\/j.ctim.2018.07.016_bib0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gutjnl-2011-300219","article-title":"The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products","volume":"61","author":"Rawsthorne","year":"2012","journal-title":"Gut"},{"issue":"March (3)","key":"10.1016\/j.ctim.2018.07.016_bib0250","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2125.2012.04350.x","article-title":"Herb-drug interactions: an overview of systematic reviews","volume":"75","author":"Posadzki","year":"2013","journal-title":"Br J Clin Pharmacol"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229918304321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229918304321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:08:14Z","timestamp":1760807294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229918304321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":50,"alternative-id":["S0965229918304321"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2018.07.016","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2018.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}